Holen Sie sich die Stockscreener-App
4.18
6.63%
0.26
Handel nachbörslich:
4.05
-0.13
-3.11%
Schlusskurs vom Vortag:
$3.92
Offen:
$3.82
24-Stunden-Volumen:
1.40M
Relative Volume:
0.17
Marktkapitalisierung:
$18.80M
Einnahmen:
$6.16M
Nettoeinkommen (Verlust:
$-14.91M
KGV:
-0.3918
EPS:
-10.6693
Netto-Cashflow:
$-9.39M
1W Leistung:
+18.08%
1M Leistung:
+301.92%
6M Leistung:
+63.28%
1J Leistung:
-79.61%
1-Tages-Spanne:
$3.77
$4.19
1-Wochen-Bereich:
$3.40
$4.71
52-Wochen-Spanne:
$0.693
$23.10
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Firmenname
Bioaffinity Technologies Inc
Sektor
Branche
Telefon
210-698-5334
Adresse
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
4.18 | 17.63M | 6.16M | -14.91M | -9.39M | -10.67 |
TMO
Thermo Fisher Scientific Inc
|
488.19 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
192.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
577.44 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.84 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.09 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten
Risk Analysis: What are the future prospects of bioAffinity Technologies Inc Equity Warrant2026 Trading Recap & Community Consensus Trade Signals - baoquankhu1.vn
UGRO, TURB, ANNA, EEIQ, BIAF: These five stocks outpaced big tech with massive March returns - MSN
BIAFW Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
BIAF Stock Gains As CyPath Sales Surge 146% In Q1 - stocktwits.com
bioAffinity Technologies, Inc.Common Stock (NQ: BIAF - The Chronicle-Journal
BIAF Stock Price $3.76 | bioAffinity Technologies, Inc. Live Quote - Meyka
bioAffinity reports 146% jump in Q1 lung test sales By Investing.com - Investing.com South Africa
BIAF stock gains as CyPath sales surge 146% in Q1 - MSN
bioAffinity Technologies’ CyPath® Lung Test Sales Surge 146% in Q1 2026, Driven by Growing Adoption for Early Lung Cancer Detection 1 - minichart.com.sg
bioAffinity Technologies, Inc. (BIAF) stock price, news, quote and history - Yahoo Finance UK
bioAffinity Reports Surge in CyPath Lung Test Sales - TipRanks
CyPath Lung sales surge 146% at bioAffinity Technologies (NASDAQ: BIAF) - Stock Titan
bioAffinity Tech Surges on Lung Cancer Study Initiative - StocksToTrade
Record Growth in bioAffinity Technologies: CyPath Lung Shines - timothysykes.com
bioAffinity reports 146% jump in Q1 lung test sales - Investing.com
bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026 - Business Wire
Earnings Beat: What hedge funds are buying bioAffinity Technologies Inc Equity Warrant2026 EndofYear Setup & Fast Exit and Entry Trade Guides - baoquankhu1.vn
BioAffinity Technologies stock cools off after strong Friday rallyhere's why - MSN
bioAffinity Technologies Appoints Three New Medical and Scientific Advisory Board Members - Medical Product Outsourcing
UGRO, TURB, ANNA, EEIQ, BIAF: These Five Stocks Outpaced Big Tech With Massive March Returns - Stocktwits
BioAffinity shares rise as CyPath Lung growth boosts optimism - MSN
Can bioAffinity Technologies Inc lead its sector in growth2026 Highlights & Low Risk High Reward Ideas - baoquankhu1.vn
Shorts Report: Is HPPPRC stock a buy or sell2026 Risk Factors & Precise Buy Zone Identification - baoquankhu1.vn
Breakout Watch: Can bioAffinity Technologies Inc Equity Warrant weather a recession2026 Stock Rankings & AI Forecast Swing Trade Picks - baoquankhu1.vn
BIAF Stock Price, Quote & Chart | BIOAFFINITY TECHNOLOGIES INC (NASDAQ:BIAF) - ChartMill
What's going on with bioAffinity Technologies stock Wednesday? - msn.com
bioAffinity Technologies Posts New Investor Presentation Materials - TipRanks
bioAffinity Technologies posts investor presentation materials on website - TradingView
bioAffinity Technologies (BIAF) shares March 2026 investor presentation materials - Stock Titan
bioAffinity Technologies Hosts Virtual Physician Roundtable on CyPath® Lung for Early Lung Cancer Detection and Pulmonary Practice Integration 123 - Minichart
bioAffinity Launches Virtual Roundtables on CyPath Lung Adoption - TipRanks
bioAffinity Technologies (BIAF) plans CyPath Lung webinar showcasing real-world clinical use - stocktitan.net
BioAffinity Technologies stock soars 120% on CyPath lung sales growth - MSN
BioAffinity’s CyPath Lung Tests Signal Powerful Growth for 2026 - timothysykes.com
BioAffinity Technologies Reports Record Growth Amid Challenges - StocksToTrade
bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice - BioSpace
What's Going On With bioAffinity Technologies Stock Wednesday? - Benzinga
bioAffinity Technologies Shows Significant Growth in Diagnostic Development - timothysykes.com
bioAffinity Technologies soars Monday as non-invasive lung cancer tech gains traction - Mugglehead Magazine
Promising Biotech Stocks To ConsiderMarch 23rd - MarketBeat
bioAffinity Technologies shares soar as investors react to upbeat CyPath Lung growth update and 2026 outlook - Quiver Quantitative
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
$bioAffinity Technologies (BIAF.US)$ It in to win it - Moomoo
If You Invested $1,000 in bioAffinity Tech (BIAF) - Stock Titan
What's going on with bioAffinity stock Thursday? - MSN
Big Money Moves: Is bioAffinity Technologies Inc affected by consumer sentimentRate Hike & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Why did BIAF stock surge 20% in pre-market today? - MSN
Top QCM Diagnostics (QCMD) Competitors 2026 - MarketBeat
BIAF Rises Amid Expansions and Innovations - timothysykes.com
Why is bioAffinity Technologies stock surging Tuesday? - MSN
Finanzdaten der Bioaffinity Technologies Inc-Aktie (BIAF)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
1.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):